← All candidates
110 insider filings on record.
110 filings on record.
ORKAOruka Therapeutics, Inc.
NasdaqGM · Healthcare · $6.19B
$93.55
+1.46% · Sep 16
110 insider filings on record.
None of them an open-market buy in the last year.
Price · 1Y · daily● 72 sells
▸ hover a marker for the filing · drag to zoom · daily bars sharpen to 30-min on close ranges · 4 moves explained
Reverse-split 6×. When a company does a reverse split, the chart rewrites its old prices to look far bigger than they really were — so the high early prices here aren't what ORKA ever actually traded at. The drop is real, but those huge old numbers aren't.
AI brief · from the filings on this pagePro
The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.
Market cap
$6.19B
Float
56.9M
86% public
Short % float
Pro
Institutional stakes
▸ a holder crossing 5% files Schedule 13D if they intend to act on the company, 13G if they certify they will not · /A amends an earlier filing
2 filingsnewest first
The record
newest first
DateTypeInsiderOf stakeShares @ priceValue
105 more transactions on Pro →Context
Wall St
$142.17 avg target
+52.0% vs today · 12 analysts · consensus Strong Buy
▸ relayed analyst opinion, which tends to run optimistic — not our forecast or advice
Earnings · EPS vs forecast
2 of 4 quarters beat
Q1 '26−$0.48 act+$0.06
Q4 '25−$0.45 act+$0.17
Q3 '25−$0.55 act−$0.03
Q2 '25−$0.46 act−$0.03
Coverage
Oruka Therapeutics, Inc. (ORKA) Upgraded to Buy: What Does It Mean for the Stock?Zacks · 06-12Wall Street Analysts Believe Oruka Therapeutics, Inc. (ORKA) Could Rally 111.13%: Here's is How to TradeZacks · 06-10An Oruka Therapeutics (ORKA) Insider Sold 105,000 Shares Worth $6.2 MillionMotley Fool · 05-31Oruka Therapeutics (ORKA) Valuation Check After Psoriasis Trial Progress Partnerships And Fresh FundingSimply Wall St. · 05-15
The file stays open
110 filings on record.
The next one will be too.
▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice